Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Genetics

Interaction and Association Analysis of a Type 1 Diabetes Susceptibility Locus on Chromosome 5q11-q13 and the 7q32 Chromosomal Region in Scandinavian Families

  1. Pernilla Holm1,
  2. Berit Rydlander1,
  3. Holger Luthman2,
  4. Ingrid Kockum1 and
  5. for the European Consortium for IDDM Genome Studies
  1. 1Department of Molecular Medicine, Karolinska Institutet, Stockholm, Sweden
  2. 2Department of Endocrinology, Lund University, Malmö, Sweden
  1. Address correspondence and reprint requests to Dr. Ingrid Kockum, Department of Molecular Medicine, Karolinska Institutet, CMM L8:00, Karolinska Hospital, S-171 76 Stockholm, Sweden. E-mail: ingrid.kockum{at}cmm.ki.se
Diabetes 2004 Jun; 53(6): 1584-1591. https://doi.org/10.2337/diabetes.53.6.1584
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Article Figures & Tables

Figures

  • Tables
  • FIG. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    Location of ISL1 gene and markers on chromosome 5p11-q13 used in this investigation. The distances in bases are shown between markers. TSC1637118 was identified by sequencing but not analyzed in our families. In the lower part of the figure, the 5′- and 3′UTRs of the ISL1 gene are shown as white boxes and exons as black boxes. ISL1:1 = rs3917084, ISL1:2 = TSC0312199, ISL1:3 = TSC0312200, ISL1:4 = TSC0424949, ISL1:5 is a newly discovered microsatellite marker (see Table 2), ISL1:6 = rs4151674, and ISL1:7 = rs4151675.

  • FIG. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    Linkage of type 1 diabetes to 50 cM on either side of D5S407 in the centromeric region of chromosome 5. The linkage contribution from each family was weighted by its LOD at D7S530 to generate a measure for interaction. The thin solid line denotes equal weight, thick solid line positive weight, and thin dotted line negative weight (see research design and methods for details). The markers used in the genome scan are indicated below the abscissa, and the centromere and the ISL1 gene are shown for location information.

Tables

  • Figures
  • TABLE 1

    Transcription factors and other key genes involved in the development and maintenance of the endocrine pancreas

    GeneChromosomeClosest markerEstimated distance between marker and geneMultipoint LOD at D5S407
    PositiveNegative
    PBX11q23D1S1963 cM1.131.25
    NeuroD/β22q32D2S1522.5 cM0.002.38
    NKX6.14q21.2-22D4S15380.8 cM2.070.24
    ISL15p11-q13D5S4075 cMNDND
    PAX47q32D7S5301.7 cM5.260.20
    NGN310q21.3D10S5372.0 cM0.421.51
    INS11p15.5TH8,000 bp2.000.58
    PAX611p13D11S9044 cM0.890.61
    D11S9071 cM0.382.04
    HNF1A12q24.2D12S3661 cM0.401.11
    D12S3424 cM0.002.02
    IPF1/PDX113q12.1D13S1920.2 cM0.002.74
    HNF6A15q21.1-q21.2CYP191 cM2.060.53
    ISL215q23D15S1140.1 cM0.751.02
    D15S1251 cM0.99*1.25
    HNF3B20p11D20S1125 cM0.321.75
    IA-120p11D20S1123 cM0.321.75
    D20S1074 cM0.003.13
    HNF4A20q12-q13.1D20S1783 cM0.461.36
    • Genotypes used for this interaction analysis were produced during a genome-wide scan for type 1 diabetes susceptibility genes (5). The interaction analysis was not presented in this report.

    • *

      * LOD for positive multipoint interaction between D15S125 and chromosome 5 was 3.2 at D5S647. ND, not determined.

  • TABLE 2

    Haplotypes in intron 1 of the ISL1 gene

    HaplotypeISL1:5ISL1:6ISL1:7Observed (non-type 1 diabetes/ type 1 diabetes)Sequence, starting at intron position + 695, counting first base after first exon as +1
    1WTAA565/561GCAATGCTCTAAAAAAAAAAAAAAAGAAAGAAAGAAAGAAAGAAAAAAACCTCCCAGAGTA*
    2WTGA36/25---------------------G---------------------------------------*
    3WT-4 bpAA10/8---------------------------------------------------------*
    4WT+8 bpGG1/2------------------------GAAAGAAA--------------------G---------------*
    • *

      * This position is 86 bp from the 5′ end of exon 2. No significant difference in frequency of the different haplotypes between patients and control subjects was observed.

  • TABLE 3

    Familial association between ISL1 and PAX4 haplotypes

    GeneMarkers included in haplotypeGlobal TDT*P valueNumber of families with transmissions to affected offspring
    ISL1ISL1:2-ISL1:30.03209
    ISL1ISL1:1-ISL1:2-ISL1:30.04208
    ISL1ISL1:1-ISL1:5-ISL1:6-ISL1:7-ISL1:2-ISL1:30.04193
    PAX4PAX4:1-PAX4:20.02209
    PAX4PAX4:2-PAX4:30.05205
    PAX4PAX4:1-PAX4:2-PAX4:30.02203
    • *

      * TDT analysis was performed using the TRANSMIT program.

  • TABLE 4

    Association analysis of ISL1 and PAX4 SNP haplotypes

    GeneISL1:1ISL1:5ISL1:6ISL1:7ISL1:2ISL1:3ISL1:4TDT*P valueTransmission (%)Observed number of transmissionsExpected number of transmissions
    ISL1TWTAAGCA0.0216.10.662.08
    ISL1TWTAAGCT0.0430.61.041.70
    ISL1TWTGAGCT0.040.1601.26
    ISL1CWTAAGTT0.0265.036.928.4
    GenePAX4:1PAX4:2PAX4:3TDT*P value
    PAX4TCC0.0016.60.594.5
    PAX4CTC0.0552.9330.9312.5
    • *

      * TDT analysis was performed using the TRANSMIT program. Because the number of transmissions are also estimated when there is not complete information in the family, the number of observed transmissions are not always integers. For ISL1 markers, haplotypes formed by 2, 3, 4, 5, and 6 markers were also analyzed, which resulted in the same haplotypes being associated as shown above. For PAX4 markers, haplotypes formed by two markers were also analyzed, resulting in the same haplotypes being associated as shown above.

  • TABLE 5

    LD estimates between markers close to ISL1 and PAX4 in 196 Swedish type 1 diabetic families

    Marker 1Marker 2Distance between markers (kb)No.dfχ2P value (<)D′
    Chromosome 5p11-q13
    D5S430ISL1:19,657600313.30.0040.32
    D5S822ISL1:11686014347.60.00010.97
    D5S822ISL1:2177605497.20.00010.39
    D5S822ISL1:31786084116.40.00010.43
    D5S822ISL1:4179382462.40.00010.40
    D5S822ISL1:5169567410.20.040.84
    D5S822ISL1:61695454110.80.00010.79
    ISL1:1ISL1:29.1593145.80.00011.00
    ISL1:1ISL1:39.3596140.70.00010.95
    ISL1:1ISL1:411376119.50.00010.83
    ISL1:5ISL1:70.02545197.50.00011.00
    ISL1:6ISL1:70.02548133.50.00011.00
    ISL1:6ISL1:28.2538116.20.00010.61
    ISL1:6ISL1:38.5535118.60.00010.65
    ISL1:6ISL1:49.8426123.80.00010.85
    ISL1:2ISL1:30.36001476.40.00010.90
    ISL1:2ISL1:41.63771299.80.00010.89
    ISL1:3ISL1:41.33771325.80.00010.94
    Chromosome 7q32
    CFTRPAX4:110,12860938.10.050.12
    PAX4:1PAX4:215571371.10.00010.82
    PAX4:1PAX4:34639180.10.00010.94
    PAX4:1D7S5302,851613410.20.040.16
    PAX4:2PAX4:33611170.50.00010.89
    • Only combinations of markers that show significant evidence of LD (P < 0.05) are shown.

PreviousNext
Back to top

In this Issue

June 2004, 53(6)
  • Table of Contents
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Interaction and Association Analysis of a Type 1 Diabetes Susceptibility Locus on Chromosome 5q11-q13 and the 7q32 Chromosomal Region in Scandinavian Families
(Your Name) has forwarded a page to you from Diabetes
(Your Name) thought you would like to see this page from the Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Interaction and Association Analysis of a Type 1 Diabetes Susceptibility Locus on Chromosome 5q11-q13 and the 7q32 Chromosomal Region in Scandinavian Families
Pernilla Holm, Berit Rydlander, Holger Luthman, Ingrid Kockum
Diabetes Jun 2004, 53 (6) 1584-1591; DOI: 10.2337/diabetes.53.6.1584

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Interaction and Association Analysis of a Type 1 Diabetes Susceptibility Locus on Chromosome 5q11-q13 and the 7q32 Chromosomal Region in Scandinavian Families
Pernilla Holm, Berit Rydlander, Holger Luthman, Ingrid Kockum
Diabetes Jun 2004, 53 (6) 1584-1591; DOI: 10.2337/diabetes.53.6.1584
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • RESEARCH DESIGN AND METHODS
    • RESULTS
    • DISCUSSION
    • APPENDIX
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • PTPN2, a Candidate Gene for Type 1 Diabetes, Modulates Pancreatic β-Cell Apoptosis via Regulation of the BH3-Only Protein Bim
  • Single Insulin-Specific CD8+ T Cells Show Characteristic Gene Expression Profiles in Human Type 1 Diabetes
  • Cesarean Section and Interferon-Induced Helicase Gene Polymorphisms Combine to Increase Childhood Type 1 Diabetes Risk
Show more Genetics

Similar Articles

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.